Skip to main
CME

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 15%
Buy 38%
Hold 31%
Sell 15%
Strong Sell 0%

Bulls say

CME Group is well positioned for durable organic growth because open interest, volume, and retail participation are all trending higher, with August ADV at 29.7M, up 10% M/M and about 6% Y/Y, while 3Q activity ran about 7% above prior modeling. Its moat remains reinforced by pricing power, including a 2% rates increase, limited client leakage to FMX, and a broadening product mix spanning single stock futures, weekend metals trading, cash foreign exchange, fixed income, and compute futures. The company also benefits from high incremental margins, strong capital return prospects, and its 27% stake in S&P Dow Jones Indexes, which should support non-operating income and future earnings growth.

Bears say

CME Group is facing a negative setup because its earnings power depends heavily on sustained trading activity and pricing, yet deceleration in Average Daily Volume and weaker Revenue per Contract trends can quickly pressure revenue. Competitive threats are also material, with FMX, CBOE, and ICE cited as potential share takers in rates, equities, and energy, while the 2007, 2008, and 2018 acquisitions add integration and execution risk if revenue or OpEx guidance disappoints. Macro sensitivity and regulatory overhang further cloud the outlook, especially as net investment income is already 10%+ of adjusted pretax income and could be disrupted if market structure shifts.

CME Group (CME) has been analyzed by 13 analysts, with a consensus rating of Hold. 15% of analysts recommend a Strong Buy, 38% recommend Buy, 31% suggest Holding, 15% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 13 analysts, CME Group (CME) has a Hold consensus rating as of Oct 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $291.08, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $291.08, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.